Scientists from IBM, Cleveland Clinic, and RIKEN have used quantum-centric supercomputing to simulate a protein complex with over 12,600 atoms, the largest such simulation on quantum hardware to date. This breakthrough, achieved by combining quantum and classical supercomputers with a novel algorithm, marks a significant step toward using quantum computing to solve complex biological problems, including drug discovery. The improved accuracy and scale could shorten drug development timelines by better predicting drug-protein interactions. This milestone demonstrates quantum computing's emerging practical role in life sciences and chemistry research.
Energy prices cooled in June, easing inflation pressures despite ongoing tensions between the U.S. and Iran near the Strait of Hormuz. Morgan Stanley reported record quarterly revenue and profit, boosted by a surge in equities trading fueled by the A...
IBM reported earnings and revenue below expectations due to enterprises reducing spending on traditional IT systems to invest in their own AI infrastructure. This shift indicates companies prefer developing on-premises AI solutions with cheaper open-...
US stock futures rose after a softer-than-expected Consumer Price Index (CPI) report reduced the chances of a Federal Reserve rate hike in July. The market now awaits today's Producer Price Index (PPI) data, which could either confirm easing inflatio...
IBM introduced Power Autonomous Operations, an AI agent that autonomously monitors and resolves issues in Power systems up to 15 times faster than manual methods, enhancing system uptime and efficiency. Alongside, IBM launched the Power S1112, a comp...
Sperax, creator of the auto-yield stablecoin USDs and SperaxOS AI agent workspace, has become an official IBM Business Partner. This partnership combines Sperax's AI-driven DeFi technology with IBM's enterprise AI and cloud infrastructure, enabling r...
